About the Alliance

The NCI Alliance for Nanotechnology in Cancer is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat, and prevent cancer. Through its programs and initiatives, the Alliance is committed to building a community of researchers dedicated to using nanotechnology to advance the fight against cancer.

As part of the Center for Strategic Scientific Initiatives which is led by NCI Deputy Director Dr. Anna Barker, the Alliance for Nanotechnology in Cancer works in concert with other NCI advanced technology initiatives to provide the scientific foundation and team science that is required to transform cancer research and care.

Mission and Goals
The NCI Alliance for Nanotechnology in Cancer is an integrated, milestone driven, and product oriented program aimed at eliminating the burden of cancer. View our mission and goals »

Our Focus
The Alliance focuses on translational research and development work across six major challenge areas, where nanotechnology can have the biggest and fastest impact. Learn about our areas of focus »

Related NCI Initiatives
In collaboration with related NCI initiatives, the Alliance is accelerating the pace of cancer research and the translation of new treatments and diagnostics to patient care. Learn about other NCI initiatives working with the Alliance »

Meet Us
By engaging researchers from across disciplines, institutions, and geographic borders, the Alliance fosters collaboration across the wider nanotechnology community. Read the bios of Alliance leadership »

Contact Us
Find contact information for the NCI Alliance for Nanotechnology in Cancer. View contact info »